Andy S Artz

34PUBLICATIONS
133CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumoursRespiratory diseasesTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 24, 2026
CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.

|Mar 05, 2026
Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS.

Lori S Muffly, Catherine J Lee, Arpita Gandhi

|Feb 11, 2026
Conventional therapy vs HMA or LDAC with or without venetoclax in older adults with AML: systematic review and meta-analysis.

Sara Ibrahim, Barbara Burgos-Mansilla, Yetiani Roldan

|Dec 01, 2025
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.

Mikkael A Sekeres, Ryan Mattison, Andrew Artz

|Nov 21, 2025
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Andrew S Artz, Brent Logan, Wael Saber

|Nov 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.

Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki

Pageof 6

Frequent Collaborators

15 joint publications

Ryotaro Nakamura

11 joint publications

Monzr M Al Malki

10 joint publications

Amandeep Salhotra

9 joint publications

Ibrahim Aldoss